121 related articles for article (PubMed ID: 21284733)
1. Gene expression of transcription factor NFATc1 in periodontal diseases.
Belibasakis GN; Emingil G; Saygan B; Turkoglu O; Atilla G; Bostanci N
APMIS; 2011 Mar; 119(3):167-72. PubMed ID: 21284733
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
3. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
5. High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes.
Vernal R; Dutzan N; Hernández M; Chandía S; Puente J; León R; García L; Del Valle I; Silva A; Gamonal J
J Periodontol; 2006 Oct; 77(10):1772-80. PubMed ID: 17032122
[TBL] [Abstract][Full Text] [Related]
6. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
[TBL] [Abstract][Full Text] [Related]
7. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
8. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease.
Cardoso CR; Garlet GP; Crippa GE; Rosa AL; Júnior WM; Rossi MA; Silva JS
Oral Microbiol Immunol; 2009 Feb; 24(1):1-6. PubMed ID: 19121062
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease.
Honda T; Aoki Y; Takahashi N; Maekawa T; Nakajima T; Ito H; Tabeta K; Okui T; Kajita K; Domon H; Yamazaki K
Clin Chim Acta; 2008 Sep; 395(1-2):137-41. PubMed ID: 18588867
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
11. Human beta defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases.
Vardar-Sengul S; Demirci T; Sen BH; Erkizan V; Kurulgan E; Baylas H
J Periodontal Res; 2007 Oct; 42(5):429-37. PubMed ID: 17760820
[TBL] [Abstract][Full Text] [Related]
12. The potential role of interleukin-17 in the immunopathology of periodontal disease.
Takahashi K; Azuma T; Motohira H; Kinane DF; Kitetsu S
J Clin Periodontol; 2005 Apr; 32(4):369-74. PubMed ID: 15811054
[TBL] [Abstract][Full Text] [Related]
13. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
14. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
[TBL] [Abstract][Full Text] [Related]
18. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
César-Neto JB; Duarte PM; de Oliveira MC; Tambeli CH; Sallum EA; Nociti FH
J Periodontal Res; 2007 Apr; 42(2):184-91. PubMed ID: 17305878
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease.
Garlet GP; Martins W; Fonseca BA; Ferreira BR; Silva JS
J Clin Periodontol; 2004 Aug; 31(8):671-9. PubMed ID: 15257746
[TBL] [Abstract][Full Text] [Related]
20. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
